chr20-58854727-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2

The ENST00000676826.2(GNAS):​c.1462G>A​(p.Ala488Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000084 in 1,535,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A488G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000086 ( 0 hom. )

Consequence

GNAS
ENST00000676826.2 missense

Scores

1
4
14

Clinical Significance

Likely benign criteria provided, single submitter U:1B:3O:1

Conservation

PhyloP100: 0.139

Publications

2 publications found
Variant links:
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS-AS1 (HGNC:24872): (GNAS antisense RNA 1) This gene produces a paternally-imprinted antisense RNA transcript that helps regulate the GNAS complex locus, which encodes the alpha subunit of the stimulatory G protein. Defects in this gene are a cause of pseudohypoparathyroidism type Ib.[provided by RefSeq, Jun 2010]
GNAS-AS1 Gene-Disease associations (from GenCC):
  • pseudohypoparathyroidism type 1B
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07264835).
BP6
Variant 20-58854727-G-A is Benign according to our data. Variant chr20-58854727-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 134496.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 10 AD,Mitochondrial,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNASNM_016592.5 linkc.*42+13841G>A intron_variant Intron 1 of 12 ENST00000371075.7 NP_057676.1 O95467-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNASENST00000676826.2 linkc.1462G>A p.Ala488Thr missense_variant Exon 1 of 13 ENSP00000504675.2 A0A7I2V5R6
GNASENST00000371102.8 linkc.1462G>A p.Ala488Thr missense_variant Exon 1 of 12 5 ENSP00000360143.4 Q5JWF2-2
GNASENST00000371075.7 linkc.*42+13841G>A intron_variant Intron 1 of 12 1 NM_016592.5 ENSP00000360115.3 O95467-1
GNASENST00000663479.2 linkc.-39+12852G>A intron_variant Intron 1 of 12 ENSP00000499353.2 A0A590UJQ9
GNASENST00000462499.6 linkc.-39+12852G>A intron_variant Intron 1 of 11 2 ENSP00000499758.2 A0A590UK28
GNASENST00000467227.6 linkc.-39+10653G>A intron_variant Intron 2 of 12 3 ENSP00000499681.2 A0A590UK28
GNASENST00000453292.7 linkc.*42+13841G>A intron_variant Intron 1 of 11 5 ENSP00000392000.2 O95467-1A2A2S1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
151902
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000122
AC:
16
AN:
131196
AF XY:
0.0000833
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000162
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000122
Gnomad OTH exome
AF:
0.000249
GnomAD4 exome
AF:
0.0000860
AC:
119
AN:
1383342
Hom.:
0
Cov.:
34
AF XY:
0.0000864
AC XY:
59
AN XY:
682646
show subpopulations
African (AFR)
AF:
0.0000317
AC:
1
AN:
31544
American (AMR)
AF:
0.000222
AC:
8
AN:
35978
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25044
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35764
South Asian (SAS)
AF:
0.000164
AC:
13
AN:
79112
European-Finnish (FIN)
AF:
0.0000292
AC:
1
AN:
34218
Middle Eastern (MID)
AF:
0.000583
AC:
3
AN:
5148
European-Non Finnish (NFE)
AF:
0.0000806
AC:
87
AN:
1078752
Other (OTH)
AF:
0.000104
AC:
6
AN:
57782
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000658
AC:
10
AN:
152012
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41474
American (AMR)
AF:
0.00
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.000624
AC:
3
AN:
4808
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67928
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000190
Hom.:
0
Bravo
AF:
0.0000831
ExAC
AF:
0.0000824
AC:
8

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:3Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

GNAS-related disorder Uncertain:1
Aug 19, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The GNAS c.1462G>A variant is predicted to result in the amino acid substitution p.Ala488Thr. This variant is located in the pre-coding region of the primary GNAS transcript (NM_000516:c.-37000G>A). This variant has been reported in a healthy, ancestrally diverse cohort (Table S1, Bodian et al. 2014. PubMed ID: 24728327). This variant is reported in 0.022% of alleles in individuals of South Asian descent in gnomAD. Although we suspect this variant may be benign, at this time, the clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. -

Pseudopseudohypoparathyroidism;C0242292:McCune-Albright syndrome;C0334041:Progressive osseous heteroplasia;C1857451:ACTH-independent macronodular adrenal hyperplasia 1;C1864100:Pseudohypoparathyroidism type 1B;C2932716:Pseudohypoparathyroidism type 1C;C3494506:Pseudohypoparathyroidism type I A;C4540135:Pituitary adenoma 3, multiple types Benign:1
Sep 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
7.9
DANN
Uncertain
0.98
DEOGEN2
Benign
0.31
T;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.43
T;T;T
M_CAP
Pathogenic
0.73
D
MetaRNN
Benign
0.073
T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.4
L;.;L
PhyloP100
0.14
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.25
N;N;N
REVEL
Benign
0.16
Sift
Uncertain
0.0020
D;T;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
0.14
B;.;.
Vest4
0.051
MutPred
0.17
Gain of glycosylation at A488 (P = 0.0017);Gain of glycosylation at A488 (P = 0.0017);Gain of glycosylation at A488 (P = 0.0017);
MVP
0.61
MPC
0.39
ClinPred
0.035
T
GERP RS
-1.3
Varity_R
0.11
gMVP
0.087
Mutation Taster
=96/4
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs552813440; hg19: chr20-57429782; COSMIC: COSV58331928; COSMIC: COSV58331928; API